Effect of Camrelizumab on Patients with Advanced Triple Negative Breast Cancer
LU Qiong
LYU Ping
Keywords:PD-1 inhibitorAdvanced triple negative breast cancerClinical effectImmune function
Publication Date:2023-10-25
Online Publishing Date:2025-08-15(First online date of this platform, not the publication date of the document)
Pages:4( 21-24 )
